Newsletter Archive
-
02.03.23 -- Why Corner Therapeutics Is Our Company To Watch
2/3/2023
02/03/23 Life Science Leader Newsletter
-
02.02.23 -- Maximizing Cell Culture Productivity
2/2/2023
02/02/23 Life Science Leader Newsletter
-
02.02.23 -- AAV Development And Manufacturing: Practical And Innovative Solutions
2/2/2023
02/02/23 Life Science Leader Newsletter
-
02.01.23 -- Why Takeda Is Focusing So Much On Plasma-Derived Therapies
2/1/2023
02/01/23 Life Science Leader Newsletter
-
02.01.23 -- Ensuring Success In Early Biopharma Formulation Development
2/1/2023
02/01/23 Life Science Leader Newsletter
-
01.30.23 -- Why Execs Are Concerned For The Future Of AI In Clinical Trials
1/30/2023
01/30/23 Life Science Leader Newsletter
-
01.30.23 -- Pediatric Patient Considerations During Dose Development
1/30/2023
01/30/23 Life Science Leader Newsletter
-
01.27.23 -- A Key Tip On How To Advance Your Career
1/27/2023
01/27/23 Life Science Leader Newsletter
-
01.25.23 -- When Partnering With A CDMO May Not Be The Best Choice
1/25/2023
01/25/23 Life Science Leader Newsletter
-
01.25.23 -- Ensure Microbial Control In The Pharmaceutical Production Environment
1/25/2023
01/25/23 Life Science Leader Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more